PSX
29
2
LRCX
61
2
GME
72
4
AAPL
65
-2
KR
52
2
PG
46
3
GT
49
2
M
55
7
KHC
13
-2
MKC
51
-2
ROST
66
4
ECL
54
-3
OMC
39
2
CVS
32
3
NWS
73
-2
HCP
54
-2
VFC
58
2
FMC
20
-2
TGNA
53
3
ZTS
43
3
PSX
29
2
LRCX
61
2
GME
72
4
AAPL
65
-2
KR
52
2
PG
46
3
GT
49
2
M
55
7
KHC
13
-2
MKC
51
-2
ROST
66
4
ECL
54
-3
OMC
39
2
CVS
32
3
NWS
73
-2
HCP
54
-2
VFC
58
2
FMC
20
-2
TGNA
53
3
ZTS
43
3
Financhill
Back

Paramount Gold Nevada Vs. Aligos Therapeutics Industry Stock Comparison

Sell
23

PZG
Paramount Gold Nevada

Last Price:
$0.32
Seasonality Move:
-2.5%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
23
Paramount Gold Nevada (PZG) is a Sell

Is Paramount Gold Nevada a Buy, Sell or Hold?

  • The current Paramount Gold Nevada [PZG] share price is $0.34. The Score for PZG is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • PZG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PZG Stock Price Chart

What is Paramount Gold Nevada's stock price today?

  • The Paramount Gold Nevada share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PZG is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

PZG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 41.35 Sell
Chaikin Money Flow: -45212 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.34 - 0.4) Sell
Bollinger Bands (100): (0.38 - 0.44) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

PZG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.34 Sell
20-day SMA: 0.36 Sell
50-day SMA: 0.38 Sell
200-day SMA: 0.43 Sell
8-day EMA: 0.34 Sell
20-day EMA: 0.35 Sell
50-day EMA: 0.38 Sell
200-day EMA: 0.4 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Paramount Gold Nevada Earnings Growth & PZG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.05 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Paramount Gold Nevada Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):